Published in Am J Gastroenterol on July 01, 2001
A genetic study of Wilson's disease in the United Kingdom. Brain (2013) 1.53
Genotype-phenotype correlations in a mountain population community with high prevalence of Wilson's disease: genetic and clinical homogeneity. PLoS One (2014) 0.86
A new mutation of Wilson's disease P-type ATPase gene in a patient with cirrhosis and coombs-positive hemolytic anemia. Dig Dis Sci (2006) 0.79
Analysis of the T1288R mutation of the Wilson disease ATP7B gene in four generations of a family: possible genotype-phenotype correlation with hepatic onset. Dig Dis Sci (2007) 0.78
The other mutation is found: follow-up of an exceptional family with Wilson disease. Am J Gastroenterol (2004) 0.77
Wilson's disease in two consecutive generations in a Bulgarian Roma family. J Neurol (2007) 0.77
An exceptional family with three consecutive generations affected by Wilson disease. JIMD Rep (2013) 0.76
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 3.59
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 2.12
ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Postcremation diagnosis from an electric shaver. Lancet (2001) 2.02
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med (1997) 1.64
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62
Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Hepatology (1991) 1.41
ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr (1997) 1.40
[Hepatitis B and C: incidence and regional distribution of hospitalizations in Austria]. Wien Klin Wochenschr (2000) 1.40
High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33
Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clin Nutr (1983) 1.25
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci (1989) 1.11
Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol (1999) 1.10
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Aliment Pharmacol Ther (2006) 1.09
Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis. Transplant Proc (2011) 1.08
The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology (1999) 1.08
Letter: comparing scoring systems and outcome of patients admitted to a liver intensive care unit with severe variceal bleeding. Aliment Pharmacol Ther (2014) 1.07
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood (2000) 1.06
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology (1989) 1.06
Autonomic neuropathy and prolongation of QT-interval in liver disease. Lancet (1992) 1.05
Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol (1991) 1.02
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. J Clin Virol (2010) 1.01
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology (1998) 1.00
Acidic colonic microclimate--possible reason for false negative hydrogen breath tests. Gut (1988) 1.00
Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease. J Hepatol (1995) 0.99
Improvement of hepatic encephalopathy treated with flumazenil. Lancet (1988) 0.98
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut (2005) 0.98
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain (2000) 0.98
Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am J Clin Pathol (2001) 0.98
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Aliment Pharmacol Ther (2012) 0.97
Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol (1995) 0.97
Hypersomnia in Wilson's disease: an unusual symptom in an unusual case. Acta Neurol Scand (2000) 0.96
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol (1997) 0.96
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol (1995) 0.95
Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology (2000) 0.95
Letter: Osteoporosis and androgens. Lancet (1976) 0.95
Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol (2006) 0.95
Epidural anesthesia? No of course. Transplant Proc (2008) 0.95
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol (1997) 0.94
Wilson's disease presenting in a family with an apparent dominant history of tremor. J Neurol Neurosurg Psychiatry (2001) 0.93
Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children. Calcif Tissue Int (2002) 0.93
Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C. Scand J Gastroenterol (2001) 0.93
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology (1987) 0.92
Experimental and human liver fibrogenesis. Scand J Gastroenterol Suppl (1998) 0.91
Energy metabolism in patients with acute and chronic liver disease. Hepatology (1990) 0.91
Brain dysfunction in fulminant hepatic failure. J Hepatol (1994) 0.90
A light stabilizer Tinuvin 770-induced toxic injury of adult rat cardiac myocytes. Forensic Sci Int (2001) 0.90
Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology (1993) 0.90
Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun (2005) 0.90
Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol (1997) 0.90
Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease. J Bone Miner Res (2002) 0.90
Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease. Lancet (1983) 0.89
Disease-associated qualitative and quantitative trait loci in proteoglycan-induced arthritis and collagen-induced arthritis. Am J Med Sci (2004) 0.88
Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C. Aliment Pharmacol Ther (2008) 0.88
Carotid body tumor in dog: a case report. Can Vet J (2007) 0.88
Stenosis of the common bile duct due to Ormond's disease: case report and review of the literature. J Hepatol (1999) 0.88
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. J Viral Hepat (2010) 0.87
Review article: genetic factors that modify the outcome of viral hepatitis. Aliment Pharmacol Ther (2014) 0.86
Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. J Hepatol (1989) 0.86
25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency. Wien Klin Wochenschr (1997) 0.86
Plasma amino acids in hepatic encephalopathy. J Neural Transm Suppl (1978) 0.85
Gamma-glutamyltranspeptidase (GGTP): its relationship to other enzymes for diagnosis of liver disease. Prog Liver Dis (1976) 0.85
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C. J Viral Hepat (2008) 0.85
Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection. J Viral Hepat (2003) 0.85
Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology (1995) 0.84
Activity of ulcerative colitis before and after liver transplantation in primary sclerosing cholangitis: the Hungarian experience. Transplant Proc (2012) 0.84
Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol (1998) 0.84
Autonomic neuropathy in liver disease. Lancet (1989) 0.84
Antibody to hepatitis B surface antigen in nonprimate animal species. Gastroenterology (1983) 0.84
First report on the occurrence of human cases of alveolar echinococcosis in the northeast of Austria. Trop Med Parasitol (1990) 0.84
Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology (1990) 0.83
Autonomic and peripheral neuropathy in primary biliary cirrhosis: evidence of small sensory fibre damage and prolongation of the QT interval. J Hepatol (1994) 0.83
[ A case of successfully treated duodenal hemangioma]. Orv Hetil (1991) 0.83
Changes in glutamate receptors on synaptic membranes associated with hepatic encephalopathy or hyperammonemia in the rabbit. Hepatology (1984) 0.83
Short-term energy balance in patients with infections: carbohydrate-based versus fat-based diets. Metabolism (1992) 0.83
Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients. Transplantation (2000) 0.82
Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr (1995) 0.82
Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation. Eur J Gastroenterol Hepatol (2000) 0.82
Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence. J Lab Clin Med (1999) 0.82
Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population. Dig Dis Sci (2000) 0.82
Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group. Transplant Proc (2011) 0.82
Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary systems. J Am Acad Dermatol (1990) 0.81
Percutaneous endovascular treatment of innominate artery lesions: a single-centre experience on 77 lesions. Eur J Vasc Endovasc Surg (2010) 0.81
A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding. Metab Brain Dis (1987) 0.81
Effect of cholestasis produced by bile duct ligation on hepatic heme and hemoprotein metabolism in rats. Gastroenterology (1983) 0.81